Dynavax Technologies Corp... (DVAX)
NASDAQ: DVAX
· Real-Time Price · USD
9.68
-0.31 (-3.10%)
At close: Jun 23, 2025, 12:50 PM
-3.10% (1D)
| Bid | 9.66 |
| Market Cap | 1.16B |
| Revenue (ttm) | 294.62M |
| Net Income (ttm) | -60.07M |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -19.35 |
| Forward PE | 19.43 |
| Analyst | Buy |
| Ask | 11.11 |
| Volume | 408,229 |
| Avg. Volume (20D) | 2,320,756 |
| Open | 10.00 |
| Previous Close | 9.99 |
| Day's Range | 9.65 - 10.04 |
| 52-Week Range | 9.22 - 14.63 |
| Beta | 1.04 |
About DVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Dynavax Technologies Corporation is scheduled to release its earnings on Aug 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-10.99%
Dynavax Technologies shares are trading lower afte...
Unlock content with
Pro Subscription
2 months ago
-6.66%
Shares of vaccine stocks are trading lower after CDC advisers begins a review of vaccine guidelines and discussed a more narrow use of COVID-19 booster shots.
1 month ago · seekingalpha.com
Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking GoodDynavax Technologies' stock has dropped 25% since my last 'Hold' rating in February 2025. The company's HEPLISAV-B continues to grow at significant rates. DVAX has ample liquidity supporting a balance...
1 month ago · seekingalpha.com
Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call TranscriptDynavax Technologies Corporation (NASDAQ:DVAX ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Paul Cox - Vice President, Investor Relations & Corporate Communications Ry...
